Transcription of The PRISMA Statement for Reporting Systematic Reviews …
{{id}} {{{paragraph}}}
Guidelines and Guidance 1. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration Alessandro Liberati1,2*, Douglas G. Altman3, Jennifer Tetzlaff4, Cynthia Mulrow5, Peter C. G tzsche6, John P. A. Ioannidis7, Mike Clarke8,9, P. J. Devereaux10, Jos Kleijnen11,12, David Moher 4,13. 1 Universita` di Modena e Reggio Emilia, Modena, Italy, 2 Centro Cochrane Italiano, Istituto Ricerche Farmacologiche Mario Negri, Milan, Italy, 3 Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom, 4 Ottawa Methods Centre, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada, 5 Annals of Internal Medicine, Philadelphia, Pennsylvania, United States of America, 6 The Nordic Cochrane Centre, Copenhagen, Denmark, 7 Depa
of that guidance. Our aim is to ensure clear presentation of what was planned, done, and found in a systematic review. Terminology used to describe systematic reviews and meta-
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
11 - Systematic Theology, 11 SYSTEMATIC THEOLOGY, Systematic Theology, INTRODUCTION, Systematic, Interim Guidance Note Systematic Operations, Interim Guidance Note Systematic Operations Risk-Rating Tool, Systematic Operations Risk-rating Tool, World Bank, The safety of buprenorphine, methadone and, Chapter 1 Introduction, NOMENCLATURE